Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Pommier

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 12, 2023
Indication and perspectives of radiation therapy in the setting of de-novo metastatic prostate cancerI Latorzeff, A Camps-Maléa, S Supiot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Phase II trial of paclitaxel and carboplatin in metastatic small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie studyP Thomas, O Castelnau, D Paillotin, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 28, 2016
Toxicity and efficacy of cetuximab associated with several modalities of IMRT for locally advanced head and neck cancerJ-E Bibault, M Morelle, L Perrier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 6, 2005
[Propositions for the selection and the delineation of peritumoral microscopic disease volumes in oral cavity and oropharyngeal cancers (lymph nodes excluded)]M Lapeyre, P Henrot, M Alfonsi, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 7, 2012
[Prospective economic evaluation of image-guided radiation therapy for prostate cancer in the framework of the national programme for innovative and costly therapies assessment]P Pommier, M Morelle, L Perrier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 9, 2006
[The French preliminary experience of the use of a seed-projector for exclusive iodine 125 prostate brachytherapy: feasibility and acute toxicity]P Pommier, M Delannes, O LeFloch, et al.
British Journal of Cancer|August 14, 2003
Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001)A Villers, P Pommier, A Bataillard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 31, 2002
[Standards, options, and recommendation for external radiotherapy of prostatic cancer: evaluation of the effect of dosage]P Pommier, A Villers, A Bataillard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 9, 2010
[Economic assessment of pulsed dose-rate (PDR) brachytherapy with optimized dose distribution for cervix carcinoma]R Remonnay, M Morelle, P Pommier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 19, 2002
[Standards, Options, and Recommendations for brachytherapy in patients with prostate cancer: efficacy and toxicity]P Pommier, A Villers, A Bataillard, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 12, 2023
Indication and perspectives of radiation therapy in the setting of de-novo metastatic prostate cancerI Latorzeff, A Camps-Maléa, S Supiot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Phase II trial of paclitaxel and carboplatin in metastatic small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie studyP Thomas, O Castelnau, D Paillotin, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 28, 2016
Toxicity and efficacy of cetuximab associated with several modalities of IMRT for locally advanced head and neck cancerJ-E Bibault, M Morelle, L Perrier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 6, 2005
[Propositions for the selection and the delineation of peritumoral microscopic disease volumes in oral cavity and oropharyngeal cancers (lymph nodes excluded)]M Lapeyre, P Henrot, M Alfonsi, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 7, 2012
[Prospective economic evaluation of image-guided radiation therapy for prostate cancer in the framework of the national programme for innovative and costly therapies assessment]P Pommier, M Morelle, L Perrier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 9, 2006
[The French preliminary experience of the use of a seed-projector for exclusive iodine 125 prostate brachytherapy: feasibility and acute toxicity]P Pommier, M Delannes, O LeFloch, et al.
British Journal of Cancer|August 14, 2003
Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001)A Villers, P Pommier, A Bataillard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 31, 2002
[Standards, options, and recommendation for external radiotherapy of prostatic cancer: evaluation of the effect of dosage]P Pommier, A Villers, A Bataillard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 9, 2010
[Economic assessment of pulsed dose-rate (PDR) brachytherapy with optimized dose distribution for cervix carcinoma]R Remonnay, M Morelle, P Pommier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 19, 2002
[Standards, Options, and Recommendations for brachytherapy in patients with prostate cancer: efficacy and toxicity]P Pommier, A Villers, A Bataillard, et al.
Pageof 10